These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30604142)

  • 1. A Combined Utilization of Plasdone-S630 and HPMCAS-HF in Ziprasidone Hydrochloride Solid Dispersion by Hot-Melt Extrusion to Enhance the Oral Bioavailability and No Food Effect.
    Xue X; Chen G; Xu X; Wang J; Wang J; Ren L
    AAPS PharmSciTech; 2019 Jan; 20(1):37. PubMed ID: 30604142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid nanocrystalline dispersions of ziprasidone with enhanced bioavailability in the fasted state.
    Thombre AG; Caldwell WB; Friesen DT; McCray SB; Sutton SC
    Mol Pharm; 2012 Dec; 9(12):3526-34. PubMed ID: 23075293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state.
    Yanfei M; Guoguang C; Lili R; Pingkai O
    Drug Dev Ind Pharm; 2015; 41(8):1353-62. PubMed ID: 25138348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Ouyang P
    J Pharm Pharmacol; 2016 Feb; 68(2):185-94. PubMed ID: 26748446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HPMCAS on recrystallization inhibition of nimodipine solid dispersions prepared by hot-melt extrusion and dissolution enhancement of nimodipine tablets.
    Zhang Q; Zhao Y; Zhao Y; Ding Z; Fan Z; Zhang H; Liu M; Wang Z; Han J
    Colloids Surf B Biointerfaces; 2018 Dec; 172():118-126. PubMed ID: 30144623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Plasdone
    Butreddy A; Sarabu S; Bandari S; Batra A; Lawal K; Chen NN; Bi V; Durig T; Repka MA
    AAPS PharmSciTech; 2021 Jun; 22(5):196. PubMed ID: 34184149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect.
    Banerjee S; Shankar KR; Prasad Y R
    Pharm Dev Technol; 2016 Nov; 21(7):775-786. PubMed ID: 26135230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
    Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
    AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
    Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
    Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
    Feng J; Xu L; Gao R; Luo Y; Tang X
    Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
    Mahmah O; Tabbakh R; Kelly A; Paradkar A
    J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Part II: bioavailability in beagle dogs of nimodipine solid dispersions prepared by hot-melt extrusion.
    Zheng X; Yang R; Zhang Y; Wang Z; Tang X; Zheng L
    Drug Dev Ind Pharm; 2007 Jul; 33(7):783-9. PubMed ID: 17654027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.
    Haware RV; Vinjamuri BP; Gavireddi M; Dave VS; Gupta D; Chougule MB; Stagner WC
    Pharm Dev Technol; 2019 Jun; 24(5):550-559. PubMed ID: 30175691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dissolution rate and oral bioavailability of Ginkgo biloba extract by preparing solid dispersion via hot-melt extrusion.
    Wang W; Kang Q; Liu N; Zhang Q; Zhang Y; Li H; Zhao B; Chen Y; Lan Y; Ma Q; Wu Q
    Fitoterapia; 2015 Apr; 102():189-97. PubMed ID: 25446043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells.
    Chowdhury N; Vhora I; Patel K; Bagde A; Kutlehria S; Singh M
    AAPS PharmSciTech; 2018 Oct; 19(7):3287-3297. PubMed ID: 30218267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach.
    Pawar J; Tayade A; Gangurde A; Moravkar K; Amin P
    Eur J Pharm Sci; 2016 Jun; 88():37-49. PubMed ID: 27049050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.